Circulating Retinol Binding Protein 4 is Inversely Associated with Pancreatic Β Cell Function Across the Spectrum of Glycemia

Rong Huang,Songping Yin,Yongxin Ye,Nixuan Chen,Shiyun Luo,Min Xia,Lina Zhao

DOI: https://doi.org/10.2337/dc19-2432

2020-01-01

Diabetes Care

Abstract:OBJECTIVE: The aim of this study was to examinethe association of circulating retinol binding protein 4 (RBP4) levels with βcell function across the spectrum of glucose tolerance from normal to overttype 2 diabetes. RESEARCH DESIGN AND METHODS: Atotal of 291 subjects aged 35-60 with normal glucose tolerance (NGT), newlydiagnosed impaired fasting glucose or glucose tolerance (IFG/IGT) and type 2diabetes were screened by standard 2-h oral glucose tolerance test (2-h OGTT)with the use of traditional measures to evaluate β cell function. 74 subjectsfrom these participants were recruited in oral minimal model test and assessedβ cell function with model-derived indices. Circulating RBP4 levels weremeasured by a commercially available ELISA kit. RESULTS: Circulating RBP4levels were significantly and inversely correlated with β cell functionindicated by the Stumvoll first-phase and second-phase insulin secretionindexes, but not with HOMA-β, calculated from the 2-h OGTT in 291 subjectsacross the spectrum of glycemia. The inverse association was also observed insubjects involved in the oral minimal model test with β cell function assessedby both direct measures and model-derived measures, after adjustment forpotential confounders. Moreover, RBP4 emerged as an independent factor of thedisposition index-total insulin secretion (DI-PhiT). CONCLUSION: CirculatingRBP4 levels are inversely and independently correlated with β cell functionacross the spectrum of glycemia, providing another possible explanation of thelinkage between RBP4 and the pathogenesis of type 2 diabetes.